188 related articles for article (PubMed ID: 10543256)
1. Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Iwafuchi M; Yamano M; Kijima H; Saito T
Jpn J Cancer Res; 1999 Aug; 90(8):841-8. PubMed ID: 10543256
[TBL] [Abstract][Full Text] [Related]
2. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.
Matsubayashi H; Watanabe H; Nishikura K; Ajioka Y; Kijima H; Saito T
Cancer; 1998 Feb; 82(4):651-60. PubMed ID: 9477096
[TBL] [Abstract][Full Text] [Related]
3. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
5. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
6. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
7. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
8. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
9. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
10. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
Cerny WL; Mangold KA; Scarpelli DG
Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642
[TBL] [Abstract][Full Text] [Related]
12. p53 protein overexpression and K-ras codon 12 mutation in pancreatic ductal carcinoma: correlation with histologic factors.
Kasuya K; Watanabe H; Nakasako T; Ajioka Y; Koyanagi Y
Pathol Int; 1997 Aug; 47(8):531-9. PubMed ID: 9293533
[TBL] [Abstract][Full Text] [Related]
13. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases.
Ren YX; Xu GM; Li ZS; Song YG
World J Gastroenterol; 2004 Mar; 10(6):881-4. PubMed ID: 15040037
[TBL] [Abstract][Full Text] [Related]
14. Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis.
Matsubayashi H; Watanabe H; Ajioka Y; Nishikura K; Yamano M; Seki T; Saito T; Matsubayashi T
Pancreas; 2000 Jul; 21(1):77-85. PubMed ID: 10881936
[TBL] [Abstract][Full Text] [Related]
15. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
16. K-Ras mutations and benign pancreatic disease.
Löhr M; Maisonneuve P; Lowenfels AB
Int J Pancreatol; 2000 Apr; 27(2):93-103. PubMed ID: 10862508
[TBL] [Abstract][Full Text] [Related]
17. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
18. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.
Watanabe H; Sawabu N; Ohta H; Satomura Y; Yamakawa O; Motoo Y; Okai T; Takahashi H; Wakabayashi T
Jpn J Cancer Res; 1993 Sep; 84(9):961-5. PubMed ID: 8407563
[TBL] [Abstract][Full Text] [Related]
19. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
20. K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters.
Tsutsumi M; Kondoh S; Noguchi O; Horiguchi K; Kobayashi E; Okita S; Ohashi K; Honoki K; Tsujiuchi T; Konishi Y
Jpn J Cancer Res; 1993 Nov; 84(11):1101-5. PubMed ID: 8276713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
